14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RAPT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

RAPT Therapeutics, Inc. stock price down 2.42% on Friday
(Updated on May 17, 2024)

Sell candidate since May 07, 2024 Loss -50.00% PDF

The RAPT Therapeutics, Inc. stock price fell by -2.42% on the last day (Friday, 17th May 2024) from $4.14 to $4.04. During the last trading day the stock fluctuated 5.02% from a day low at $4.03 to a day high of $4.23. The price has fallen in 8 of the last 10 days and is down by -51.5% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -58 thousand shares and in total, 537 thousand shares were bought and sold for approximately $2.17 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.85 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -30.95% during the next 3 months and, with a 90% probability hold a price between $2.66 and $4.88 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RAPT Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, May 14, 2024, and so far it has risen 1.00%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The RAPT Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.26 and $7.43. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for RAPT Therapeutics, Inc. stock

RAPT Therapeutics, Inc. finds support from accumulated volume at $4.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.202 between high and low, or 5.02%. For the last week, the stock has had daily average volatility of 6.05%.

RAPT Therapeutics, Inc. is oversold on RSI14 (17). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RAPT) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect RAPT Therapeutics, Inc. to open at $4.10, and during the day (based on 14 day Average True Range), to move between $3.50 and $4.58, which gives a possible trading interval of +/-$0.536 (+/-13.26%) up or down from last closing price. If RAPT Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 26.53% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.00 (0.99%) than the resistance at $4.25 (5.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is RAPT Therapeutics, Inc. stock A Buy?

RAPT Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.110 Sell Candidate Unchanged

Predicted Opening Price for RAPT Therapeutics, Inc. of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
$4.10 ( 1.50%) $4.04

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RAPT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.30 6.51 %
R2 4.23 4.60 %
R1 4.18 3.42 %
Current price: 4.04
Support S1 4.02 -0.409 %
S2 3.98 -1.59 %
S3 3.90 -3.50 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.66 15.35 %
R2 4.33 7.18 %
R1 4.25 5.07 %
Current price 4.04
Support S1 4.00 -0.99%
S2 0 .
S3 0 .

FAQ

What is the symbol for RAPT Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for RAPT Therapeutics, Inc. is RAPT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell RAPT Therapeutics, Inc. Stock?
RAPT Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy RAPT Therapeutics, Inc. Stock?
RAPT Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy RAPT Therapeutics, Inc. Stock.

What's the current price of RAPT Therapeutics, Inc. Stock?
As of the end of day on the May 17, 2024, the price of an RAPT Therapeutics, Inc. (RAPT) share was $4.04.

What is the 52-week high and low for RAPT Therapeutics, Inc. Stock?
The 52-week high for RAPT Therapeutics, Inc. Stock is $27.35 and the 52-week low is $3.98.

What is the market capitalization of RAPT Therapeutics, Inc. Stock?
As of the May 17, 2024, the market capitalization of RAPT Therapeutics, Inc. is 141.01M.

When is the next earnings date for RAPT Therapeutics, Inc.?
The upcoming earnings date for RAPT Therapeutics, Inc. is Aug 09, 2024.
Click to get the best stock tips daily for free!

About RAPT Therapeutics, Inc.

RAPT Therapeutics. RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead onco... RAPT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT